Vivos Therapeutics, Inc. (VVOS) 是一家上市公司 属于 医疗保健 板块,经营于 Medical - Devices 行业. 公司总部位于 Highlands Ranch, CO, 美国. 现任CEO为 R. Kirk Huntsman.
VVOS 拥有 IPO日期为 2020-12-11, 109 名全职员工, 在 NASDAQ Capital Marke, 市值为 $7.95M.
Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers the Vivos System, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. Vivos Therapeutics also offers VivoScore Program, a screening and home sleep test in adults and children. The company markets and sells its Vivos System to licensed professionals, primarily general dentists in the United States and Canada. Vivos Therapeutics, Inc. was founded in 2016 and is based in Highlands Ranch, Colorado.